Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2009;53:654-660
Published online before print February 23, 2009, doi: 10.1161/HYPERTENSIONAHA.108.125831
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
53/4/654    most recent
HYPERTENSIONAHA.108.125831v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ball, C. J.
Right arrow Articles by Beltrame, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ball, C. J.
Right arrow Articles by Beltrame, J. F.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Other Vascular biology
Right arrowRelated Article

(Hypertension. 2009;53:654.)
© 2009 American Heart Association, Inc.


Original Articles

Heterogeneity of L- and T-Channels in the Vasculature

Rationale for the Efficacy of Combined L- and T-Blockade

Christine J. Ball; David P. Wilson; Stuart P. Turner; David A. Saint; John F. Beltrame

From the Cardiology Research Laboratory, Queen Elizabeth Hospital (C.J.B., D.P.W., S.P.T., J.F.B.), and Department of Physiology, School of Molecular and Biomedical Science (D.P.W., D.A.S., J.F.B.), University of Adelaide, Adelaide, Australia.

Correspondence to John F. Beltrame, Cardiology Research Laboratory, Queen Elizabeth Hospital, University of Adelaide, 28 Woodville Rd, Woodville South, SA 5011, Australia. E-mail john.beltrame{at}adelaide.edu.au

Clinical studies suggest that T-type Ca2+ channel blockade may have incremental benefits over conventional L-channel blockade, particularly in microvascular disorders. This study examined functional vasomotor differences in L- and T-channel blockade between large and small vessels and compared the abundance of the L- and T-type channels in these vessels. The inhibition of endothelin-1 and potassium-induced vascular contractile responses by L-channel blockers (verapamil and nifedipine) was compared with combined L- and T-channel blockers (mibefradil and efonidipine) in large (rat aorta) and small (rat mesenteric and human subcutaneous) vessels using wire myography. All 4 of the Ca2+ channel blockers inhibited contractile responses to a similar extent in large rat vessels; however, in rat microvessels, the combined L- and T-channel blockers produced significantly greater inhibition of contraction than L-channel blockers alone. The significance of this differential T-channel effect in microvessels was further supported by the following: (1) a greater abundance of T-channels compared with L-channels in microvessels but not in large vessels; (2) demonstration of divergent Ca2+ channel blocker responses in human microvessels; (3) incremental inhibition of constrictor responses with combined L- and T-Ca2+ channel blockers despite maximal L-channel blockade; (4) the use of structurally diverse Ca2+ channel blockers with varied affinity for L- and T-channels; (5) the use of pharmacodynamically and therapeutically appropriate Ca2+ channel blocker concentrations; (6) confirmation of contractile agonist independent responses; and (7) exclusion of an endothelium-dependent mechanism. We propose that T-type channels play an important role in regulating contractile responses in the microvasculature and, therefore, are a potential therapeutic target.


Key Words: calcium • calcium channel blockers • vessels • vasoconstriction • vasculature


Related Article:

Combined L-/T-Type Calcium Channel Blockers: Ready for Prime Time
Wei Ge and Jun Ren
Hypertension 2009 53: 592-594. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
JAMAHome page
J. F. Beltrame and P. Ganz
Evaluating Patients With Persistent Chest Pain and No Obstructive Coronary Artery Disease
JAMA, August 12, 2009; 302(6): 622 - 623.
[Full Text] [PDF]


Home page
HypertensionHome page
T. Godfraind
Is Combined L- and T-Channel Blockade Better Than L-Channel Blockade in Therapy?
Hypertension, July 1, 2009; 54(1): e3 - e3.
[Full Text] [PDF]


Home page
HypertensionHome page
W. Ge and J. Ren
Combined L-/T-Type Calcium Channel Blockers: Ready for Prime Time
Hypertension, April 1, 2009; 53(4): 592 - 594.
[Full Text] [PDF]